Aims and Scope of Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology is a scientific journal for original research pertaining to action of chemicals, drugs, or natural products to animals or humans. The journal covers mechanistic approaches to physiological, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Less
Key Metrics
CiteScore 

7.1
Impact Factor 

< 5
SJR 

Q1Toxicology

SNIP 

0.97
Recommended pre-submission checks
Powered by 

Topics Covered on Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1959 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Toxicology and Applied Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Toxicology and Applied Pharmacology
A fully human antibody A140 neutralizes abrin toxin via lysosomal intracellular mechanisms, confers potent protection in vitro and in vivo, and reverses transcriptomic dysregulation with a Favorable safety profile.
- 1 Sep 2026
- Toxicology and applied pharmacology
Brefeldin A induces apoptosis in cisplatin-resistant ovarian cancer cells independent of ABCC2-mediated drug efflux.
- 1 Sep 2026
- Toxicology and applied pharmacology
In vitro assessment of the osteotoxic potential of diuron in human BMSCs.
- 1 Sep 2026
- Toxicology and applied pharmacology
Asiaticoside alleviates metabolic associated fatty liver disease via PI3K/AKT/mTOR signaling pathway.
- 1 Sep 2026
- Toxicology and applied pharmacology
Corynoxine suppresses hepatocellular carcinoma progression by forming the ROS-STAT3 cycle.
- 1 Sep 2026
- Toxicology and applied pharmacology
Etanercept suppresses rheumatoid arthritis development via modulating miR-125a-3p.
- 1 Sep 2026
- Toxicology and applied pharmacology
A fully human antibody A140 neutralizes abrin toxin via lysosomal intracellular mechanisms, confers potent protection in vitro and in vivo, and reverses transcriptomic dysregulation with a Favorable safety profile.
- 1 Sep 2026
- Toxicology and applied pharmacology
Brefeldin A induces apoptosis in cisplatin-resistant ovarian cancer cells independent of ABCC2-mediated drug efflux.
- 1 Sep 2026
- Toxicology and applied pharmacology
In vitro assessment of the osteotoxic potential of diuron in human BMSCs.
- 1 Sep 2026
- Toxicology and applied pharmacology
Asiaticoside alleviates metabolic associated fatty liver disease via PI3K/AKT/mTOR signaling pathway.
- 1 Sep 2026
- Toxicology and applied pharmacology
Corynoxine suppresses hepatocellular carcinoma progression by forming the ROS-STAT3 cycle.
- 1 Sep 2026
- Toxicology and applied pharmacology
Etanercept suppresses rheumatoid arthritis development via modulating miR-125a-3p.
- 1 Sep 2026
- Toxicology and applied pharmacology